Target intelligence / Profile preview

Guanine nucleotide-binding protein (G protein)

Target
G protein
Molecular classification
Enzyme, Signal transducer, Small GTPase, Heterotrimeric protein complex
01

Overview

Guanine nucleotide-binding proteins, commonly called G proteins, are a superfamily of proteins functioning as molecular switches in cells, transmitting signals from various extracellular stimuli to intracellular responses[5]. Their activity depends on binding and hydrolyzing GTP and GDP. G proteins fall into two major classes: heterotrimeric G proteins (composed of alpha, beta, and gamma subunits) and small GTPases (monomeric, such as those in the Ras superfamily)[5]. Heterotrimeric G proteins are activated by G protein-coupled receptors (GPCRs), leading to a cascade of downstream signaling events affecting enzymes, ion channels, and cellular functions. Small GTPases also participate in signal transduction but regulate other processes such as cytoskeletal dynamics and vesicular trafficking. G proteins and their signaling pathways are central in controlling cell metabolism, growth, differentiation, and survival, making them important therapeutic targets or disease drivers in oncology, neurology, and other fields[5].

Other names
GTP-binding proteinGTPaseSmall GTPaseHeterotrimeric G proteinRas superfamily GTPase
02

Mechanism of action

Activation or inhibition of downstream effectors by binding/hydrolyzing GTP/GDP; Mediation of signals from GPCRs via subunit release (alpha, beta-gamma); Regulation of enzymatic activity and ion channel function through protein–protein interaction

03

Biological functions

Signal transductionRegulation of metabolic enzymesControl of ion channelsRegulation of cell motilityRegulation of secretionCell proliferationCell differentiationEmbryonic developmentHomeostasis
04

Disease associations

CancerCardiovascular diseaseNeurodegenerative diseaseMetabolic diseaseDevelopmental disorders
05

Safety considerations

Off-target systemic effects due to the ubiquity of G protein signalingOncogenic mutations (e.g., constitutively active mutant forms in cancer)Dysregulation leading to metabolic or neurological side effects
06

Interacting drugs

Cholera toxin (activates Gs)

2 more in the full profile.

07

Biomarkers

Mutation status (e.g., KRAS mutation in tumors)Expression levels of specific G protein subunits in disease contexts

Beyond the preview

Go deeper on Guanine nucleotide-binding protein (G protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanine nucleotide-binding protein (G protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call